+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Novo Nordisk A/S - logo

Novo Nordisk is a global healthcare company with more than 90 years of innovation and leadership in diabetes care. Key products include diabetes care medications and devices. Novo Nordisk is also involved with hemostasis management, growth hormone therapy and hormone replacement therapy. Headquartered in Denmark, Novo Nordisk employs approximately 40,000 employees in 75 countries, and markets its products in more than 180 countries.

Europe Therapeutic Devices Market Outlook, 2028 - Product Thumbnail Image

Europe Therapeutic Devices Market Outlook, 2028

  • Report
  • November 2023
  • 122 Pages
  • Europe
From
North America Therapeutic Devices Market Outlook, 2028 - Product Thumbnail Image

North America Therapeutic Devices Market Outlook, 2028

  • Report
  • November 2023
  • 119 Pages
  • North America
From
Therapeutic Devices Market Outlook, 2028 - Product Thumbnail Image

Therapeutic Devices Market Outlook, 2028

  • Report
  • November 2023
  • 190 Pages
  • Global
From
Growth Hormone (GH) Agonist - Pipeline Insight, 2025 - Product Thumbnail Image

Growth Hormone (GH) Agonist - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Malaysian Diabetes Devices Market, Forecast to 2023 - Product Thumbnail Image

Malaysian Diabetes Devices Market, Forecast to 2023

  • Report
  • February 2020
  • 80 Pages
  • Malaysia
From
Thai Diabetes Devices Market, Forecast to 2023 - Product Thumbnail Image

Thai Diabetes Devices Market, Forecast to 2023

  • Report
  • February 2020
  • 80 Pages
  • Thailand
From
Loading Indicator